24 HR bupropion hydrobromide 522 MG Extended Release Oral Tablet

RxCUI: 993681
RxNorm name: 24 HR bupropion hydrobromide 522 MG Extended Release Oral Tablet
Display name: 24 HR bupropion hydrobromide 522 MG Extended Release Oral Tablet
Full name: 24 HR bupropion hydrobromide 522 MG Extended Release Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Bupropion Hydrobromide	BUPROPION HYDROBROMIDE	Oceanside Pharmaceuticals	3ec04240-baef-44d7-8d73-a181171eec43	2026-06-01	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 993681
Aplenzin	BUPROPION HYDROBROMIDE	Bausch Health US, LLC	6494d2d9-0ce4-4126-b1c7-49684395942b	2026-03-04	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 993681

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6494d2d9-0ce4-4126-b1c7-49684395942b	24 HR bupropion hydrobromide 522 MG Extended Release Oral Tablet	SCD	27	These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN ® (bupropion hydrobromide) extended-release tablets, for oral use Initial U.S. Approval: 1985	20260304
6494d2d9-0ce4-4126-b1c7-49684395942b	buPROPion HBr 522 MG 24HR Extended Release Oral Tablet	PSN	27	These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN ® (bupropion hydrobromide) extended-release tablets, for oral use Initial U.S. Approval: 1985	20260304
6494d2d9-0ce4-4126-b1c7-49684395942b	bupropion hydrobromide 522 MG 24 HR Extended Release Oral Tablet	SY	27	These highlights do not include all the information needed to use APLENZIN safely and effectively. See full prescribing information for APLENZIN. APLENZIN ® (bupropion hydrobromide) extended-release tablets, for oral use Initial U.S. Approval: 1985	20260304